Tekmira Pharmaceuticals Corp (NASDAQ:TKMR)

11.63
Delayed Data
As of Jul 02
 -0.08 / -0.68%
Today’s Change
8.86
Today|||52-Week Range
29.93
-23.23%
Year-to-Date

Today’s Trading

Previous close11.71
Today’s open11.50
Day’s range11.50 - 11.96
Volume307,197
Average volume (3 months)700,517
Market cap$642.9M
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-95.65%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-3.31%
P/E ratio--
Price/Sales22.17
Price/Book3.02

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...-0.53-3.08%
ADXSAdvaxis Inc-0.44-2.33%
CORTCorcept Therapeutics...0.000.00%
OREXOrexigen Therapeutic...-0.17-3.45%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$15.0M
Annual profit (last year)-$38.8M
Net profit margin-259.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Operating Officer
Patrick T. Higgins
Corporate headquarters
Burnaby, British Columbia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers